Post-acute Rehabilitation

 

Interview: Charles Wang, Group CEO, Luye Medical Group

Formed as recently as 2015, Singapore-based Luye Medical Group has become one of the major contenders in health care services across China, Australia and SE Asia. It is part of the Luye Life Sciences Group which owns Luye Pharma Group, one of the largest pharmaceutical companies in China and separately listed on the Hong Kong Stock Exchange. Luye Medical Group acquired Healthe Care, the third largest Australian for-profit hospital operators in 2016. It has since expanded its business rapidly adding healthcare operations such as oncology (Singapore), inpatient, outpatient and community based health care services (Australia) and rehabilitation and maternity hospitals (China). The aim, says Wang, is mainly to provide a value-based healthcare experience to meet the needs of the middle class and patients with private insurance coverage across SE Asia, Australia and China. Here we talk to him about Luye Medical Group’s plans and how it views the Chinese market. Wang is a speaker at HBI 2018, the global health care service event in London from April 10 to 11.

Paracelsus closing hospital after it fails to find a buyer

The Karlsruhe-Durlach acute care clinic of German hospital and rehab group Paracelsus will close at the end of February after negotiations with buyers ground to a halt. We hear that the big hospital groups have been circling around the company's highly profitable rehab units, while it wants to get rid of its loss-making hospitals.

Nordic chain cracks America and looks to the world

A Nordic addiction clinic chain has cracked America, licensing its methodology to two North American groups and is now looking at international expansion in Far East Asia and the Middle East, including taking equity in partners. It claims that its outpatient approach achieves better results than inpatient rehab at a tenth of the cost and puts the size of the US addiction treatment market at $35bn.

The lucrative, luxurious post-birth care business in China

Professional postpartum care - luxury live-in care for both mother and child in the month following childbirth - has evolved into a lucrative business in China in less than a decade. Healthcare Nova speaks to John Yue Zhao, founder and CEO of the Xi Yue Ge care centre to find out more.

Median looks to ehealth

We talk to Andre Schmidt, CEO of Median, the largest inpatient rehab group and a major player in psychiatric conditions about digital health and outpatient. In 2017 the pension fund payors approved a legal framework which allows them to pay providers for ehealth and for sessions delivered remotely.

Intercare deal could be a game-changer

This summer, Mediclinic, the listed South African, Europe and Mid-East hospital giant, quietly bought into Intercare, a South African outpatient, day hospital and sub-acute and rehabilitation hospital network which specialises in value-based healthcare, providing the best outcomes at the lowest costs. Here is why we think the acquisition is a game changer and why this is a business model that could be exported internationally.

Waterland scotches Median for-sale rumours

Rumours that the private equity firm Waterland will sell the German rehabilitation giant have started to circulate. We put them to partner Dr Carsten Rahlfs and discussed the future of the market and acute care group ATOS.

Brazilian care group to triple revenue in 18 months, says CEO

Brasil Senior Living (BSL), which claims to be Brazil’s largest long-term care company, is to triple its number of beds and revenue in the next 18 months, according to its CEO Ricardo Soares. He tells Healthcare Nova the long-term care market in Brazil is still in its infancy.

Find Us